Registry of Patients With Acute/Subacute Type B Aortic Dissection Treated by Means of the STABILISE Technique (STABILISE)

Inclusion Criteria:

- Patients with ≥ 18 years of age;

- Patients presenting with an acute (up to two weeks from the onset) and subacute
(between 3 and 12 weeks from the onset) type B dissection with a proximal suitable
non-dissected landing zone in the aortic arch or descending thoracic aorta
(supra-aortic trunks debranching may be employed to obtain an adequate proximal
landing zone);

- Total aortic diameter of the abdominal aorta (from supra-celiac to infra-renal level)
must not exceed 42 mm;

- Patients able to sign specific informed consent for the study.

Exclusion Criteria:

- Patients with chronic type B aortic dissection (more than 12 weeks from the onset);

- Patients with acute type B aortic dissection not treated according to the following
treatment protocol;

- Unwilling or unable to comply with the follow-up schedule;

- Inability or refusal to give informed consent;

- Simultaneously participating in another investigative device or drug study;

- Frank rupture;

- Systemic infection (eg, sepsis);

- Allergy to stainless steel, polyester, solder (tin, silver), polypropylene, nitinol,
or gold;

- Untreatable reaction to contrast, which, in the opinion of the investigator, cannot be
adequately premedicated;

- Surgical or endovascular AAA repair within 30 days before or after dissection repair;

- Previous placement of a thoracic endovascular graft;

- Prior open repair involving the descending thoracic aorta, including the supra-renal
aorta and/or arch;

- Interventional and/or open surgical procedures (unrelated to dissection) within 30
days before or after dissection repair.